about
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include S...
Read More
2.52
0.07
(2.86%)
3.9M
XNAS Volume
XNAS 16 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Gossamer Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..